Work

MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS

Year: 2018

Type: article

Source: Carcinogenesis

DOI: 10.1093/carcin/bgy022

Authors: Zhi-liang Wang, Chuan-bao Zhang, Zheng Wang, Xiang-qi Meng, Xiao-juan Liu, Bo Han, Chun-bin Duan, Jin-quan Cai, Zhong-fei Hao, Ming-hui Chen, Tao Jiang, Yong-li Li, Chuan-lu Jiang, Hong-jun Wang

Institutions: Capital Medical University, Beijing Tian Tan Hospital, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Heilongjiang Province

Awards: G1047630621, G2719286663, G5229789043, G6080556946, G6260605913, G7054053505, G7395671053

OpenAlex ID: W2791611501

FWCI: 0.271

Cites: 46

Cited by: 9

Related to: 10